A1M Pharma’s scientific advisory board has extensive experience and unique knowledge of pre-eclampsia, oxidative stress, kidney injuries and drug development. The group supports A1M’s R&D work and participates in the long-term strategy development for medical applications.


Michael Brownstein
Scientific Consultant

Michael Brownstein is a Scientist Emeritus at the National Institutes of Health in Bethesda, Maryland, USA. He currently works mainly as a consultant and has helped to establish a number of successful biotechnology companies. In his academic career, he was an active researcher in, among other fields, neurobiology, pharmacology and genetics.



Gunvor Ekman-Ordeberg
Professor in obstetrics and gynaecology at Karolinska Institutet (KI)

Gunvor Ekman-Ordeberg is a researcher at KI and a senior consultant at Karolinska University Hospital. Her research focuses on, among other topics, connective tissue remodelling in the uterus and the cervix during pregnancy and birth. Two companies have been formed at KI as a result of her research.



Tony Kettle
Professor in pathology at University of Otago Christchurch, New Zealand

Anthony James Kettle is a research professor at the Department of Pathology at University of Otago Christchurch. For approximately 20 years, he has been studying the enzyme myeloperoxidase and the role it plays in immune defence and inflammatory tissue damage.



Christopher Redman
Professor Emeritus of Obstetric Medicine at the Nuffield Department of Obstetrics & Gynaecology at University of Oxford

Christopher Redman has spent four decades working in the field of pre-eclampsia and has contributed greatly to our understanding of the origins, diagnosis, prevention and treatment of the condition. He is regarded by many as one of the world’s leading pre-eclampsia researchers.



Henning Schneider
Professor Emeritus of Obstetrics and Gynaecology at the University of Bern.

Henning Schneider is following up his lengthy career as a research clinician at the women’s hospital in Bern by collaborating with a network of research groups in Europe and the USA – all of which focus on the biology of the placenta. One of his experimental models is based on ex-vivo perfusion, which enables placental function to be studied in cases of pre-eclampsia, for example.



József Balla
Professor of Medicine, University of Debrecen, Hungary.

József Balla is head of the Department of Nephrology and Hemodialysis at the University of Debrecen in Hungary. He has participated in a number of academic projects, been the principal investigator for clinical trials, and is a member of the Hungarian medicines agency’s scientific advisory board. His research has focused on, among other areas, oxidative stress and the harmful effects of heme.
A1M Pharma AB | Scheelevägen 22 | 223 63 Lund
+46 46 286 50 30 | info@a1m.se
Medlem av Preeclampsia Foundation
Legal disclaimer | © Copyright - A1M